Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Argus Health
Fish and Richardson
Moodys
McKinsey
Daiichi Sankyo
Harvard Business School
Medtronic
Fuji
QuintilesIMS

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,492,897

« Back to Dashboard

Summary for Patent: 5,492,897
Title: Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives
Abstract:6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumor therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed.
Inventor(s): Krenitsky; Thomas A. (Chapel Hill, NC), Averett; Devron R. (Raleigh, NC), Koszalka; George W. (Chapel Hill, NC), Wolberg; Gerald (Cary, NC)
Assignee: Burroughs Wellcome Co. (141) (Research Triangle Park, NC)
Application Number:08/224,343
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,492,897

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,492,897

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9015914Jul 19, 1990

International Patents Family Members for US Patent 5,492,897

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ireland 912513 ➤ Subscribe
Germany 69125715 ➤ Subscribe
Denmark 0539479 ➤ Subscribe
European Patent Office 0539479 ➤ Subscribe
Spain 2103311 ➤ Subscribe
United Kingdom 9015914 ➤ Subscribe
Greece 3023776 ➤ Subscribe
Hungary T62911 ➤ Subscribe
Hungary 9300115 ➤ Subscribe
Cyprus 2165 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Fish and Richardson
Queensland Health
Medtronic
Chubb
Colorcon
Cipla
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot